Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bergamot Polyphenol Extract Reduces Hepatocyte Neutral Fat by Increasing Beta-Oxidation

20 Aug 2022

Abstract excerpt

Background: Bergamot polyphenolic fraction (PF) extract exerts a beneficial against liver steatosis. However, the fundamental processes underlying this beneficial effect of bergamot PF remain elusive. In this work, we examined the effect of bergamot PF extract on 2D and 3D hepatocyte cultures. Material and Methods: We evaluated the effect of bergamot PF in 2D and 3D cultures from rat, human hepatoma cells, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug-Induced Hepatotoxicity and Protection
Share to Liver Disease Diagnosis and Treatment
Share to Liver physiology and pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36014938
DOI: 10.3390/nu14163434

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bergamot Polyphenol Extract Reduces Hepatocyte Neutral Fat by Increasing Beta-OxidationPMID 36014938Read ↗

Dramatic Suppression of Lipogenesis and No Increase in Beta- Oxidation Are the Main Effects of Bergamot Flavonoids on Gene Expression in Fatty Liver DiseaseSemantic proximity Read ↗

Ketogenic Diet Ameliorates NAFLD via Balancing Mitochondrial Dynamics and Improving Mitochondrial DysfunctionSemantic proximity Read ↗

Micropatterned Primary Hepatocyte Co-Culture (HEPATOPAC) for Fatty Liver Disease Modeling and Drug ScreeningSemantic proximity Read ↗

Treatment with a polyherbal extract improves fat metabolism, attenuates hepatic stellate cell activation and fibrogenesisSemantic proximity Read ↗

The effect of oleoylethanolamide supplementation on pyroptotic cell death in obese patients with non-alcoholic fatty liver disease: A double-blinded randomized controlled clinical trialSemantic proximity Read ↗

A 1,2,3-Triazole Derivative Mitigates Palmitic Acid-Induced Lipotoxicity Through Coordinated Modulation of Lipogenic, Oxidative, and Inflammatory Pathways in HepG2 CellsSemantic proximity Read ↗

Characterization of diseased primary human hepatocytes in an all-human cell-based triculture systemSemantic proximity Read ↗

A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice.Semantic proximity Read ↗

Transcriptome and translatome analyses reveal the regulatory role of betaine in high fat diet (HFD)-induced hepatic steatosisSemantic proximity Read ↗

Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid OxidationSemantic proximity Read ↗

Natural Extracts Abolished Lipid Accumulation in Cells Harbouring non-favourable PNPLA3 genotype.Semantic proximity Read ↗

Exendin-4 alleviates hepatic steatosis by lowering FABP1 and raising FOXA1 expression via the Wnt/-catenin signaling pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.